Serious question - How will ColluMauxil Therapeutics differentiate its products?
Without the CBD snake oil, how are they going to profitably compete with Bengay?
A tube of Bengay retails for under $10, and TAUG's subsidiary is not going to be able to use distribution as a strategic advantage against JNJ's Bengay. So why would folks buy it?
IMO, they won't.
But I'm all ears about any credible reason why they would.
Unfortunately, I anticipate deafening silence. Prove me wrong!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.